All Out Liquid Vaporizer: Category Creation to Public-Health Education

Industry & Competitive Context

The Indian household insecticide market through the 1990s and 2000s was structured around four dominant formats — mosquito coils, mats, aerosols, and liquid vaporizers — and was contested by a small set of large players. By 2008, Reckitt Benckiser's Mortein held roughly 29% value share, Jyothy Laboratories' Maxo held about 22%, and Godrej Sara Lee's Good Knight held around 20%, with category volumes split across mats (50%), vaporizers (20%), coils (10%), aerosols (5%), and other formats (10%), according to an analysis published in Vikalpa, the journal of the Indian Institute of Management Ahmedabad. This period's four major competitors were Reckitt Benckiser (Mortein), Jyothy Laboratories (Maxo), Godrej Sara Lee (Good Knight), and Karamchand Appliances Private Limited — KAPL — with All Out. What distinguishes this case is that KAPL was not competing across an existing category; it focused specifically on promoting vaporizers at a time when the format did not yet exist as a meaningful category in India, while established competitors concentrated on coils and mats. All Out is described in case literature as almost a generic name for liquid vaporizers, within what was documented as a Rs 4 billion mosquito-repellent industry as of 1999.

Brand Situation Prior to Campaign

KAPL, the company behind All Out, was "perhaps not a familiar name for the average Indian consumer," yet it was almost solely responsible for creating the liquid-vaporizer segment. This mattered structurally: KAPL was a newcomer with a single product, competing against GSLL and Reckitt & Coleman (later Reckitt Benckiser), both multi-product giants with well-established distribution networks already in place before entering the vaporizer category. Documented case analysis notes that "Place" was the one element of the marketing mix in which KAPL trailed its major competitors, since GSLL and R&C could leverage existing multi-category distribution while KAPL could not. On product economics, All Out entered as a premium, first-of-its-kind product using technology sourced from Japan, initially priced from Rs 225 before this was later reduced, and the format itself transitioned over time from corded to plug-in variants.

Strategic Objective

KAPL's documented objective was twofold: first, to create and own an entirely new product category rather than compete within the established coil-and-mat segments where larger FMCG incumbents held structural advantages; and second, once larger competitors recognized the category's growth potential and entered with their own vaporizer variants, to defend and extend leadership within it. This strategy rested on three documented pillars — technological innovation, first-mover advantage, and aggressive marketing.

Campaign Architecture & Execution

The brand's advertising history is unusually well documented because of a specific pivot in how it was produced. KAPL had initially used an external agency whose work was described by an industry observer as "humorous and attention-grabbing," but as lacking clarity on "what the brand wanted to say." KAPL subsequently decided to handle All Out's advertising on its own — a move that surprised industry watchers and drew criticism from ad agencies at the time. That in-house effort produced the brand's signature asset: a campaign featuring an animated jumping frog — in fact a stylized rendering of the All Out vaporizer itself — shown eating mosquitoes, which proved immensely successful and was based on a similar advertisement originally made by Earth for the Japanese market. A later iteration added a human competitor trying to out-eat the frog in a mosquito-eating contest and losing. Notably, the short advertisement cost KAPL only Rs 50,000 to produce, and the company continued running it with only minor modifications over several years to coincide with new promotional schemes. Media placement was equally unconventional. KAPL advertised heavily on videocassettes of Hindi films, a distribution choice that drew criticism from advertising agencies because such placements were widely regarded as reaching narrower or lower-income audiences. Frequency, too, became a documented point of contention: television viewers reportedly expressed frustration that the brand's advertisements ran before every song, dance, and fight sequence across broadcast films, and industry experts noted that once a brand was firmly established, such repetitive advertising was inadvisable and could turn counterproductive. The brand also faced public criticism of its product claims. Reports at the time noted the product contained a variant of the toxic compound d-Allethrin, and critics argued that marketing claims around "Extra MMR" implied more, not less, exposure to toxic components.

Positioning & Consumer Insight

All Out's underlying insight was behavioral rather than technical: Indian households associated mosquito protection with coils and mats, and had to be persuaded that a plug-in liquid format was both effective and worth a premium. The frog-eating-mosquitoes device converted a functional claim (kills mosquitoes) into a memorable, low-cost visual metaphor that required no dependence on scale-driven media spend to achieve recall — a necessity given KAPL's distribution disadvantage against multi-product incumbents.

Media & Channel Strategy

Beyond television, KAPL's channel choices centered on Hindi-film videocassettes as a distribution vehicle for its advertisement, a strategy publicly criticized by advertising agencies even as it appears to have supported the brand's recall. No verified public information is available on formal media-mix ratios, specific channel budgets, or agency-of-record details for this era beyond KAPL's decision to produce work in-house.

Business & Brand Outcomes (Historical Phase)

Market-share outcomes are documented, with two figures appearing across independent sources. One case summary states All Out, launched in 1990, "became the market leader with 60% share within a decade," while other case documentation specifically cites a 69% share figure for 1999. A separate case-study source corroborates the latter, stating All Out dominated "the Rs. 4 billion liquid vaporizer market in India with a 69% share in 1999," gained despite competition from Godrej Sara Lee Ltd and Hindustan Lever Ltd. The variation between 60% and 69% likely reflects differing measurement periods or category definitions, but both are independently documented and consistent with a position of clear category leadership. External validation followed: KAPL's promoters — Anil, Bimal, and Naveen Arya — were named "Marketing Persons of the Year" at the 2000 Advertising & Marketing (A&M) awards, an independent, third-party recognition of the brand's marketing-led growth. The brand's competitive position was not without pressure. A later case document notes that by the time competitors such as Good Knight intensified their challenge, All Out's share had settled at around 45%, placing the brand in the maturity stage of its life cycle, and recommending strategies such as new variants, rural distribution expansion, and anti-counterfeiting campaigns to defend position. Separately, KAPL is documented as having responded to competitive pressure with promotional offers aimed at regaining share. On ownership: KAPL's All Out business was later acquired by S.C. Johnson & Son, a transition reflected in subsequent product listings that name S C Johnson Products Pvt Ltd as the brand's manufacturer/marketer, and the brand today operates under Brillon Consumer Products Private Limited — a joint venture between S C Johnson Pvt Ltd and the private equity firm Bansk Group, with a portfolio spanning All Out, Mr. Muscle, Baygon, Glade, Dranex, and Kiwi — a company on record as formerly named S C Johnson Products Private Limited, led by Managing Director Ratanjit Das. No verified public information is available on the financial terms of the original KAPL-to-SC Johnson transaction.

The Shift to Educational Campaigns

Over the past decade, All Out's public communications have moved from category-creation advertising toward structured public-health education, executed through partnerships with health bodies and media houses rather than solely through owned advertising.

Fight Dengue For Payal (2013). SC Johnson, then owner of All Out, partnered with the Voluntary Health Association of India (VHAI) to launch "Fight Dengue For Payal," an awareness campaign designed to educate the public on preventive measures against dengue. The campaign was named after Payal Samariya, a 12-year-old girl from Jaipur who had witnessed a friend suffer from the disease, and was publicly supported by actress Sonali Bendre.

Fight Dengue for Your Family (2014, global). SC Johnson's corporate global campaign "Fight Dengue for Your Family" was extended in 2014 to Ribeirão Preto, Brazil, in partnership with the local government, three private schools, and NGO Saúde Solidária, involving educational rallies and school programs. Kelly M. Semrau, then SVP of Global Corporate Affairs, Communication & Sustainability for SC Johnson, stated the company saw a responsibility, as "a global citizen and expert in pest control products," to increase community awareness of these diseases and provide access to education resources.

Saath Ladenge Dengue Se — TV9/IMA phase (2025). Marking World Dengue Day 2025, TV9 Network partnered with the Indian Medical Association (IMA) and All Out to launch "Saath Ladenge Dengue Se," broadcast across six of TV9's regional channels and digital platforms with expert insights, short informative segments, and a national panel discussion. The rollout spanned TV9's Hindi, Kannada, Telugu, Marathi, Bangla, and Gujarati channels, alongside Instagram reels, Facebook explainers, and X threads, culminating in a televised panel on TV9 Bharatvarsh bringing together doctors, public health experts, and IMA representatives. Ratanjit Das, MD & CEO of Brillon Consumer Products, said awareness of vector-borne disease remained low in India and that, with dengue rising, the company wanted to "increase our efforts on educating consumers and work with credible partners to create mass awareness." Dr Dilip Bhanushali, National President of the IMA, framed the effort as a public-health priority requiring collective, multi-stakeholder action.

Saath Ladenge Dengue Se — OMD/India Today phase (2026). In June 2026, All Out, alongside Omnicom Media's OMD India and the India Today Group, extended the "Saath Ladenge Dengue Se" initiative into a nationwide public-awareness campaign, unveiled with an expert-led discussion involving healthcare professionals, government representatives, and policymakers. Its rollout used doctor-led explainers, short-format awareness content, influencer collaborations, podcasts, and special programming across Aaj Tak, India Today TV, Good News Today, The Lallantop, and digital platforms. Ratanjit Das noted that India accounts for nearly one-third of the global dengue burden, and that a significant share of the population remains unaware of how the disease spreads and how it can be prevented. OMD India CEO Anisha Iyer described the intent as using "the scale and credibility of trusted media platforms to turn awareness into participation." Across both 2025 and 2026 phases, the "Saath Ladenge Dengue Se" ("We will fight dengue together") platform reflects a consistent strategic logic: pairing the brand with credible third-party validators — a medical association and established news broadcasters — rather than relying on owned brand advertising alone. No verified public information is available on campaign reach, audience metrics, media spend, or any measured shift in dengue-prevention behavior resulting from either phase.

Strategic Implications

All Out's history illustrates two distinct, sequential strategic plays. The first — category creation against multi-product incumbents with superior distribution — relied on product innovation (Japanese vaporizer technology, cord-to-plug transition) combined with disproportionately effective, low-cost creative (a Rs 50,000 advertisement sustained for years) to compensate for a structural distribution disadvantage. This is a classic small-challenger playbook: win on salience and category ownership where you cannot win on shelf reach. The second — the shift toward "Saath Ladenge Dengue Se" — represents a repositioning from product advertising to cause-linked public education, executed through partnerships that lend the brand institutional credibility (IMA) and media distribution scale (TV9, India Today Group, OMD) that a single FMCG brand could not generate through paid media alone. This mirrors a broader pattern documented in SC Johnson's own history, dating back to at least 2013–2014, of using disease-awareness partnerships as a recurring corporate-affairs vehicle across markets, rather than a one-off India-specific initiative. A caution embedded in the brand's own history is worth carrying forward: the documented criticism of over-frequency in the 1990s–2000s advertisement placements is a reminder that sustained share-of-voice strategies, however effective initially, carry a wear-out risk that experts flagged even while the brand was market leader.

Discussion Questions

1. KAPL succeeded in creating and leading the liquid-vaporizer category despite a documented distribution disadvantage against multi-product FMCG incumbents. What does this suggest about the conditions under which a single-product challenger can defend a category it created once larger competitors enter?

   
   

2. All Out's signature advertisement cost only Rs 50,000 and ran with minimal changes for years, yet also drew criticism for repetitive overexposure. How should a brand manager balance creative consistency (for recall) against wear-out risk, particularly for a low-cost, high-frequency asset?

   
   

3. All Out's advertising placement on Hindi-film videocassettes was criticized by agencies at the time yet appears to have coincided with rapid share growth. What does this tell us about the gap between "conventional" media-planning wisdom and channel choices that fit a brand's specific consumer base?

   
   

4. The shift from product-benefit advertising (mosquito-killing efficacy) to cause-linked public health education (dengue awareness, in partnership with the IMA and national broadcasters) marks a repositioning of the brand's public voice. What are the strategic risks and benefits of an FMCG brand aligning its communications with public-health messaging rather than product performance?

   
   

5. Two market-share figures for All Out (60% and 69%) appear across otherwise credible case sources, without a clearly reconciled methodology. As a case-study reader, how should one treat such discrepancies when using historical case material to inform present-day strategic recommendations?